Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Whipple

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancers|November 27, 2024
Real-World Outcomes of Selective <i>RET</i> Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two DatabasesChi-Yin Liao, Carmen Gonzalez-Ferrer, Samuel Whipple, et al.
Cancer Treatment and Research Communications|April 28, 2026
Evaluation of guideline-recommended care in first-line treatment for advanced/metastatic non-small cell lung cancer patients who underwent next-generation sequencing testing: results from a real-world studyMelina E Marmarelis, Adrienne M Gilligan, Tomoko Sugihara, et al.
Clinical Pharmacology and Therapeutics|July 28, 2019
Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled TrialsGillis Carrigan, Samuel Whipple, William B Capra, et al.
Nature|April 8, 2021
Evaluating eligibility criteria of oncology trials using real-world data and AIRuishan Liu, Shemra Rizzo, Samuel Whipple, et al.
Pharmacoepidemiology and Drug Safety|March 16, 2019
An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records databaseGillis Carrigan, Samuel Whipple, Michael D Taylor, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancers|November 27, 2024
Real-World Outcomes of Selective <i>RET</i> Inhibitor Selpercatinib in the United States: Descriptive, Retrospective Findings from Two DatabasesChi-Yin Liao, Carmen Gonzalez-Ferrer, Samuel Whipple, et al.
Cancer Treatment and Research Communications|April 28, 2026
Evaluation of guideline-recommended care in first-line treatment for advanced/metastatic non-small cell lung cancer patients who underwent next-generation sequencing testing: results from a real-world studyMelina E Marmarelis, Adrienne M Gilligan, Tomoko Sugihara, et al.
Clinical Pharmacology and Therapeutics|July 28, 2019
Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled TrialsGillis Carrigan, Samuel Whipple, William B Capra, et al.
Nature|April 8, 2021
Evaluating eligibility criteria of oncology trials using real-world data and AIRuishan Liu, Shemra Rizzo, Samuel Whipple, et al.
Pharmacoepidemiology and Drug Safety|March 16, 2019
An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records databaseGillis Carrigan, Samuel Whipple, Michael D Taylor, et al.
Pageof 1